Loading company…
MyLife Technologies develops nanoporous microneedle arrays for vaccine and drug delivery.
MyLife Technologies develops nanoporous microneedle arrays and ceramic skin patches to deliver vaccines and pharmaceutical ingredients through the skin. It works with pharmaceutical and biopharmaceutical companies on delivery systems for infectious diseases, tumors and other applications. Founded in 2012, the company is based in Leiden, Netherlands. In November 2021, it raised EUR 3.5 million from Fare Capital and Sal Beheer B.V. for vaccine patch production and clinical studies.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in